Search Results for citation:"90 FR 13179"

The National Institute on Aging has announced a closed meeting, set for April 9, 2025, from 1:00 p.m. to 4:00 p.m. This meeting will be conducted virtually and will focus on reviewing and evaluating grant applications related to clinical trials for aging conditions. The meeting is closed to the public to protect confidential information, such as trade secrets, patentable material, and personal data concerning individuals linked to the grant applications. For any inquiries, Dr. Maurizio Grimaldi serves as the contact person for this event.

The National Institute on Aging has announced a closed virtual meeting concerning clinical trials for managing early- and late-stage Alzheimer's Disease (AD). The meeting is scheduled for April 11, 2025, and will be held from 10:00 a.m. to 5:00 p.m. It will focus on reviewing and evaluating grant applications, and the discussions may involve confidential information. The contact for the meeting is Dr. Maurizio Grimaldi, whose contact details are provided for further inquiries.

The notice informs about a closed meeting of the Board of Scientific Counselors for the National Institute of Dental and Craniofacial Research, scheduled for May 29, 2025. This meeting will be virtual and closed to the public due to the evaluation of individual research programs and personnel qualifications. The meeting is organized in compliance with privacy laws to prevent unnecessary invasion of personal privacy. For more information, Yun Mei, MD, can be contacted at the National Institute of Dental and Craniofacial Research.

The National Heart, Lung, and Blood Institute has announced two upcoming meetings that will be closed to the public due to privacy and confidentiality concerns. These meetings, set for April 23, 2025, will involve reviewing and evaluating contract proposals and grant applications related to heart, lung, blood, and sleep disorders research. Both meetings will be held virtually at the National Institutes of Health in Bethesda, Maryland. The meetings are intended to discuss sensitive information such as trade secrets and personal data associated with the applications.